Scherpereel A, Antonia S, Bautista Y, Grossi F, et al. First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743. Lung Cancer 2022;167:8-16.
PMID: 35367910